{"transactions":[{"id":844343,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-13T20:20:56.000Z","date":"2026-03-11","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 11, 2026), with the final monthly installment vesting no later than the nearest trading day on the Nasdaq Global Select Market preceding the 2027 annual meeting of stockholders."}],"balance_after":20000,"derivative":{"exercise_price":14.17,"expiration_date":"2036-03-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0002064832-26-000143","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000206483226000143/form4.xml","form_type":"4"}},{"id":1206010,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-14T21:44:01.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 13, 2025), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2026 annual meeting of stockholders."}],"balance_after":15700,"derivative":{"exercise_price":6.83,"expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001062993-25-005507","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299325005507/form4.xml","form_type":"4"}},{"id":1587272,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-08T22:30:24.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":15700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 6, 2024), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2025 annual meeting of stockholders."}],"balance_after":15700,"derivative":{"exercise_price":15.66,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":15700},"source":{"system":"sec-edgar","filing":"0001062993-24-006052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299324006052/form4.xml","form_type":"4"}},{"id":1709620,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-16T01:08:21.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":15295,"price":9.12,"value":139490.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.56, inclusive. The reporting person undertakes to provide to Enanta Pharmaceuticals, Inc., any security holder of Enanta Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."}],"balance_after":5800,"source":{"system":"sec-edgar","filing":"0001062993-23-022695","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299323022695/form4.xml","form_type":"4"}},{"id":1947713,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-17T22:46:26.000Z","date":"2023-03-16","kind":"exercise","acquired":false,"shares":5800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":14,"expiration_date":"2023-03-20","underlying":"Common Stock","underlying_shares":5800},"source":{"system":"sec-edgar","filing":"0001062993-23-007225","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299323007225/form4.xml","form_type":"4"}},{"id":1947712,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-17T22:46:26.000Z","date":"2023-03-16","kind":"exercise","acquired":true,"shares":5800,"price":14,"value":81200.0,"ownership":{"direct":true},"balance_after":21095,"source":{"system":"sec-edgar","filing":"0001062993-23-007225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299323007225/form4.xml","form_type":"4"}},{"id":1969566,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-06T22:21:50.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":10800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 2, 2023), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2024 annual meeting of stockholders."}],"balance_after":10800,"derivative":{"exercise_price":47.72,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":10800},"source":{"system":"sec-edgar","filing":"0001062993-23-006097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299323006097/form4.xml","form_type":"4"}},{"id":2348400,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-07T23:52:25.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 3, 2022), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2023 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":68.22,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001062993-22-007013","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000106299322007013/form4.xml","form_type":"4"}},{"id":2809240,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-04T23:45:26.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 2, 2021), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2022 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":49.92,"expiration_date":"2031-03-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001177648-21-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764821000019/edgar.xml","form_type":"4"}},{"id":3241499,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-28T22:24:01.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 26, 2020), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2021 annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":51.04,"expiration_date":"2030-02-26","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001177648-20-000020","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764820000020/edgar.xml","form_type":"4"}},{"id":3623462,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-03-02T01:08:09.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 28, 2019), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2020 annual meeting of stockholders."}],"balance_after":5000,"derivative":{"exercise_price":102.54,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001177648-19-000024","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764819000024/edgar.xml","form_type":"4"}},{"id":4015866,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-06T00:36:36.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 28, 2018), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2019 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":78.62,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001177648-18-000019","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000019/edgar.xml","form_type":"4"}},{"id":4436284,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":61042,"kind":"person","name":"Vance Terry","position":1,"cik":"0001572282","reported_name":"Vance Terry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-22T00:42:23.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 16, 2017), with the final monthly installment vesting at the 2018 annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":29.02,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001177648-17-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764817000018/edgar.xml","form_type":"4"}}]}